Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

Oral versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplantation Recipients.

Foolad F, Aitken SL, Shigle TL, Prayag A, Ghantoji S, Ariza-Heredia E, Chemaly RF.

Clin Infect Dis. 2018 Sep 8. doi: 10.1093/cid/ciy760. [Epub ahead of print]

PMID:
30202920
2.

Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies.

Vakil E, Sheshadri A, Faiz SA, Shah DP, Zhu Y, Li L, Kmeid J, Azzi J, Balagani A, Bashoura L, Ariza-Heredia E, Chemaly RF.

Transpl Infect Dis. 2018 Sep 8:e12994. doi: 10.1111/tid.12994. [Epub ahead of print]

PMID:
30195271
3.

Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials.

Chemaly RF, Chou S, Einsele H, Griffiths P, Avery R, Razonable RR, Mullane KM, Kotton C, Lundgren J, Komatsu TE, Lischka P, Josephson F, Douglas CM, Umeh O, Miller V, Ljungman P; Resistant Definitions Working Group of the Cytomegalovirus Drug Development Forum.

Clin Infect Dis. 2018 Aug 22. doi: 10.1093/cid/ciy696. [Epub ahead of print]

PMID:
30137245
4.

Leukopenia and lack of ribavirin predict poor outcomes in patients with haematological malignancies and respiratory syncytial virus infection.

Azzi JM, Kyvernitakis A, Shah DP, El Haddad L, Mahajan SN, Ghantoji SS, Heredia-Ariza E, Chemaly RF.

J Antimicrob Chemother. 2018 Aug 2. doi: 10.1093/jac/dky311. [Epub ahead of print]

PMID:
30113677
5.

Letermovir for the prevention of cytomegalovirus infection in adult cytomegalovirus-seropositive hematopoietic stem cell transplant recipients.

Foolad F, Aitken SL, Chemaly RF.

Expert Rev Clin Pharmacol. 2018 Sep 18:1-11. doi: 10.1080/17512433.2018.1500897. [Epub ahead of print]

PMID:
30004790
6.

Update on infection control practices in cancer hospitals.

Ariza-Heredia EJ, Chemaly RF.

CA Cancer J Clin. 2018 Jul 9. doi: 10.3322/caac.21462. [Epub ahead of print] Review.

7.

Progression of the Radiologic Severity Index predicts mortality in patients with parainfluenza virus-associated lower respiratory infections.

Sheshadri A, Shah DP, Godoy M, Erasmus JJ, Song J, Li L, Evans SE, Chemaly RF, Dickey BF, Ost DE.

PLoS One. 2018 May 17;13(5):e0197418. doi: 10.1371/journal.pone.0197418. eCollection 2018.

8.

Delay of alternative antiviral therapy and poor outcomes of acyclovir-resistant herpes simplex virus infections in recipients of allogeneic stem cell transplant - a retrospective study.

Ariza-Heredia EJ, Chemaly RF, Shahani LR, Jang Y, Champlin RE, Mulanovich VE.

Transpl Int. 2018 Jun;31(6):639-648. doi: 10.1111/tri.13142. Epub 2018 Mar 13.

PMID:
29464765
9.

Comparison of Palivizumab-Like Antibody Binding to Different Conformations of the RSV F Protein in RSV-Infected Adult Hematopoietic Cell Transplant Recipients.

Ye X, Iwuchukwu OP, Avadhanula V, Aideyan LO, McBride TJ, Ferlic-Stark LL, Patel KD, Piedra FA, Shah DP, Chemaly RF, Piedra PA.

J Infect Dis. 2018 Mar 28;217(8):1247-1256. doi: 10.1093/infdis/jiy026.

PMID:
29365155
10.

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation.

Marty FM, Ljungman P, Chemaly RF, Maertens J, Dadwal SS, Duarte RF, Haider S, Ullmann AJ, Katayama Y, Brown J, Mullane KM, Boeckh M, Blumberg EA, Einsele H, Snydman DR, Kanda Y, DiNubile MJ, Teal VL, Wan H, Murata Y, Kartsonis NA, Leavitt RY, Badshah C.

N Engl J Med. 2017 Dec 21;377(25):2433-2444. doi: 10.1056/NEJMoa1706640. Epub 2017 Dec 6.

11.

Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.

Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC, Cogdill AP, Zhao L, Hudgens CW, Hutchinson DS, Manzo T, Petaccia de Macedo M, Cotechini T, Kumar T, Chen WS, Reddy SM, Szczepaniak Sloane R, Galloway-Pena J, Jiang H, Chen PL, Shpall EJ, Rezvani K, Alousi AM, Chemaly RF, Shelburne S, Vence LM, Okhuysen PC, Jensen VB, Swennes AG, McAllister F, Marcelo Riquelme Sanchez E, Zhang Y, Le Chatelier E, Zitvogel L, Pons N, Austin-Breneman JL, Haydu LE, Burton EM, Gardner JM, Sirmans E, Hu J, Lazar AJ, Tsujikawa T, Diab A, Tawbi H, Glitza IC, Hwu WJ, Patel SP, Woodman SE, Amaria RN, Davies MA, Gershenwald JE, Hwu P, Lee JE, Zhang J, Coussens LM, Cooper ZA, Futreal PA, Daniel CR, Ajami NJ, Petrosino JF, Tetzlaff MT, Sharma P, Allison JP, Jenq RR, Wargo JA.

Science. 2018 Jan 5;359(6371):97-103. doi: 10.1126/science.aan4236. Epub 2017 Nov 2.

12.

Evaluation of a pulsed xenon ultraviolet disinfection system to decrease bacterial contamination in operating rooms.

El Haddad L, Ghantoji SS, Stibich M, Fleming JB, Segal C, Ware KM, Chemaly RF.

BMC Infect Dis. 2017 Oct 10;17(1):672. doi: 10.1186/s12879-017-2792-z.

13.

Prevention of Cytomegalovirus Reactivation in Haploidentical Stem Cell Transplantation.

Hammerstrom AE, Lombardi LR, Pingali SR, Rondon G, Chen J, Milton DR, Chemaly RF, Champlin RE, Gulbis A, Ciurea SO.

Biol Blood Marrow Transplant. 2018 Feb;24(2):353-358. doi: 10.1016/j.bbmt.2017.09.018. Epub 2017 Oct 3.

PMID:
28986189
14.

Influenza in patients with hematological malignancies: Experience at two comprehensive cancer centers.

Vilar-Compte D, Shah DP, Vanichanan J, Cornejo-Juarez P, Garcia-Horton A, Volkow P, Chemaly RF.

J Med Virol. 2018 Jan;90(1):50-60. doi: 10.1002/jmv.24930. Epub 2017 Sep 14.

PMID:
28851056
15.

A MULTICENTER, LONGITUDINAL, INTERVENTIONAL, DOUBLE BLIND RANDOMIZED CLINICAL TRIAL IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS RESIDING IN REMOTE AREAS: LESSONS LEARNED FROM THE LATE CYTOMEGALOVIRUS PREVENTION TRIAL.

Kimball LE, Stevens-Ayers T, Green ML, Xie H, Flowers ME, Jerome KR, LeBlanc R, Dahlgren C, Nichols WG, Chemaly RF, Papanicolaou G, Boeckh M.

Contemp Clin Trials Commun. 2016 Dec 15;4:84-89. doi: 10.1016/j.conctc.2016.05.002. Epub 2016 May 5.

16.

Burden of human metapneumovirus infections in patients with cancer: Risk factors and outcomes.

El Chaer F, Shah DP, Kmeid J, Ariza-Heredia EJ, Hosing CM, Mulanovich VE, Chemaly RF.

Cancer. 2017 Jun 15;123(12):2329-2337. doi: 10.1002/cncr.30599. Epub 2017 Feb 8.

17.

Antiviral therapy for respiratory viral infections in immunocompromised patients.

Shahani L, Ariza-Heredia EJ, Chemaly RF.

Expert Rev Anti Infect Ther. 2017 Apr;15(4):401-415. doi: 10.1080/14787210.2017.1279970. Epub 2017 Jan 16. Review.

PMID:
28067078
18.

Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial.

Grimley MS, Chemaly RF, Englund JA, Kurtzberg J, Chittick G, Brundage TM, Bae A, Morrison ME, Prasad VK.

Biol Blood Marrow Transplant. 2017 Mar;23(3):512-521. doi: 10.1016/j.bbmt.2016.12.621. Epub 2017 Jan 5.

19.

The characteristics of patients with mycobacterium tuberculosis blood stream infections in Beijing, China: a retrospective study.

Liu X, Bian S, Zhang Y, Zhang L, Yang Q, Wang P, Xu Y, Shi X, Zhang Y, Chemaly RF.

BMC Infect Dis. 2016 Dec 12;16(1):750.

20.

Staphylococcus lugdunensis infections, filling in the gaps: a 3-year retrospective review from a comprehensive cancer center.

Nesher L, Tarrand J, Chemaly RF, Rolston KV.

Support Care Cancer. 2017 Apr;25(4):1063-1069. doi: 10.1007/s00520-016-3493-7. Epub 2016 Nov 24.

21.

Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients.

Abudayyeh A, Hamdi A, Abdelrahim M, Lin H, Page VD, Rondon G, Andersson BS, Afrough A, Martinez CS, Tarrand JJ, Kontoyiannis DP, Marin D, Gaber AO, Oran B, Chemaly RF, Ahmed S, Abudayyeh I, Olson A, Jones R, Popat U, Champlin RE, Shpall EJ, Rezvani K.

Transpl Infect Dis. 2017 Feb;19(1). doi: 10.1111/tid.12632. Epub 2016 Dec 28.

PMID:
27862740
22.

Adjuvant and salvage therapy with leflunomide for recalcitrant cytomegalovirus infections in hematopoietic cell transplantation recipients: A case series.

El Chaer F, Mori N, Shah D, Oliver N, Wang E, Jan A, Doan V, Tverdek F, Tayar J, Ariza-Heredia E, Chemaly RF.

Antiviral Res. 2016 Nov;135:91-96. doi: 10.1016/j.antiviral.2016.08.027. Epub 2016 Sep 1.

PMID:
27594527
23.

How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients.

El Chaer F, Shah DP, Chemaly RF.

Blood. 2016 Dec 8;128(23):2624-2636. Epub 2016 Oct 19.

24.

Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience.

El-Haddad D, El Chaer F, Vanichanan J, Shah DP, Ariza-Heredia EJ, Mulanovich VE, Gulbis AM, Shpall EJ, Chemaly RF.

Antiviral Res. 2016 Oct;134:58-62. doi: 10.1016/j.antiviral.2016.08.024. Epub 2016 Aug 28.

PMID:
27582067
25.

Challenges in Determining Genotypes for Pharmacogenetics in Allogeneic Hematopoietic Cell Transplant Recipients.

Langman LJ, Nesher L, Shah DP, Azzi JM, Shpall EJ, Rezvani K, Black JL 3rd, Chemaly RF.

J Mol Diagn. 2016 Sep;18(5):638-642. doi: 10.1016/j.jmoldx.2016.03.007. Epub 2016 Jun 29.

26.

High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center.

Aitken SL, Tarrand JJ, Deshpande LM, Tverdek FP, Jones AL, Shelburne SA, Prince RA, Bhatti MM, Rolston KVI, Jones RN, Castanheira M, Chemaly RF.

Clin Infect Dis. 2016 Oct 1;63(7):954-958. doi: 10.1093/cid/ciw398. Epub 2016 Jun 16.

PMID:
27313265
27.

Human metapneumovirus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic review.

Shah DP, Shah PK, Azzi JM, El Chaer F, Chemaly RF.

Cancer Lett. 2016 Aug 28;379(1):100-6. doi: 10.1016/j.canlet.2016.05.035. Epub 2016 May 31. Review.

28.

Aerosolized ribavirin: the most expensive drug for pneumonia.

Chemaly RF, Aitken SL, Wolfe CR, Jain R, Boeckh MJ.

Transpl Infect Dis. 2016 Aug;18(4):634-6. doi: 10.1111/tid.12551. Epub 2016 Jul 5.

PMID:
27214684
29.

Association of increased influenza vaccination in health care workers with a reduction in nosocomial influenza infections in cancer patients.

Frenzel E, Chemaly RF, Ariza-Heredia E, Jiang Y, Shah DP, Thomas G, Graviss L, Raad I.

Am J Infect Control. 2016 Sep 1;44(9):1016-21. doi: 10.1016/j.ajic.2016.03.024. Epub 2016 May 5.

PMID:
27158088
30.

The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia.

Galloway-Peña JR, Smith DP, Sahasrabhojane P, Ajami NJ, Wadsworth WD, Daver NG, Chemaly RF, Marsh L, Ghantoji SS, Pemmaraju N, Garcia-Manero G, Rezvani K, Alousi AM, Wargo JA, Shpall EJ, Futreal PA, Guindani M, Petrosino JF, Kontoyiannis DP, Shelburne SA.

Cancer. 2016 Jul 15;122(14):2186-96. doi: 10.1002/cncr.30039. Epub 2016 May 3.

31.

Utility of the Enzyme-Linked Immunospot Interferon-γ-Release Assay to Predict the Risk of Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients.

Nesher L, Shah DP, Ariza-Heredia EJ, Azzi JM, Siddiqui HK, Ghantoji SS, Marsh LY, Michailidis L, Makedonas G, Rezvani K, Shpall EJ, Chemaly RF.

J Infect Dis. 2016 Jun 1;213(11):1701-7. doi: 10.1093/infdis/jiw064. Epub 2016 Feb 11.

32.

Outcomes of Influenza Infections in Hematopoietic Cell Transplant Recipients: Application of an Immunodeficiency Scoring Index.

Kmeid J, Vanichanan J, Shah DP, El Chaer F, Azzi J, Ariza-Heredia EJ, Hosing C, Mulanovich V, Chemaly RF.

Biol Blood Marrow Transplant. 2016 Mar;22(3):542-8. doi: 10.1016/j.bbmt.2015.11.015. Epub 2015 Nov 27.

33.

Pharmacokinetics and safety of intravesicular cidofovir in allogeneic HSCT recipients.

Aitken SL, Zhou J, Ghantoji SS, Kontoyiannis DP, Jones RB, Tam VH, Chemaly RF.

J Antimicrob Chemother. 2016 Mar;71(3):727-30. doi: 10.1093/jac/dkv393. Epub 2015 Nov 26.

PMID:
26612873
34.

Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients.

Abudayyeh A, Hamdi A, Lin H, Abdelrahim M, Rondon G, Andersson BS, Afrough A, Martinez CS, Tarrand JJ, Kontoyiannis DP, Marin D, Gaber AO, Salahudeen A, Oran B, Chemaly RF, Olson A, Jones R, Popat U, Champlin RE, Shpall EJ, Winkelmayer WC, Rezvani K.

Am J Transplant. 2016 May;16(5):1492-502. doi: 10.1111/ajt.13635. Epub 2016 Mar 2.

35.

Parainfluenza virus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic review.

Shah DP, Shah PK, Azzi JM, Chemaly RF.

Cancer Lett. 2016 Jan 28;370(2):358-64. doi: 10.1016/j.canlet.2015.11.014. Epub 2015 Nov 12. Review.

36.

Implementation of a Pan-Genomic Approach to Investigate Holobiont-Infecting Microbe Interaction: A Case Report of a Leukemic Patient with Invasive Mucormycosis.

Shelburne SA, Ajami NJ, Chibucos MC, Beird HC, Tarrand J, Galloway-Peña J, Albert N, Chemaly RF, Ghantoji SS, Marsh L, Pemmaraju N, Andreeff M, Shpall EJ, Wargo JA, Rezvani K, Alousi A, Bruno VM, Futreal PA, Petrosino JF, Kontoyiannis DP.

PLoS One. 2015 Nov 10;10(11):e0139851. doi: 10.1371/journal.pone.0139851. eCollection 2015.

37.

Innovative Analysis of the Sequenced Patterns of Vancomycin-Resistant Enterococci Strains to Determine Clonal Transmission in a Hospital Setting.

Chemaly RF, Ghantoji SS, Huber T, Raad II, Jinadatha C, Stibich M.

Infect Control Hosp Epidemiol. 2015 Dec;36(12):1461-3. doi: 10.1017/ice.2015.208. Epub 2015 Sep 2.

PMID:
26329908
38.

Influenza vaccination in patients with cancer: factors associated with vaccination practices for patients and their household members.

Ariza-Heredia EJ, Azzi J, Shah DP, Nesher L, Ghantoji SS, Michailidis L, Marsh L, Chemaly RF.

Infect Control Hosp Epidemiol. 2015 Oct;36(10):1239-41. doi: 10.1017/ice.2015.150. Epub 2015 Jul 1.

PMID:
26132392
39.

Practical review of immunizations in adult patients with cancer.

Ariza-Heredia EJ, Chemaly RF.

Hum Vaccin Immunother. 2015;11(11):2606-14. doi: 10.1080/21645515.2015.1062189. Epub 2015 Jun 25. Review.

40.

Ertapenem usage in cancer patients with and without neutropenia: a report on 97 cases from a comprehensive cancer center.

Nesher L, Tverdek FP, Mahajan SN, Chemaly RF, Rolston KV.

Infection. 2015 Oct;43(5):545-50. doi: 10.1007/s15010-015-0784-8. Epub 2015 May 1.

PMID:
25929421
41.

General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation.

Saliba RM, Rezvani K, Leen A, Jorgensen J, Shah N, Hosing C, Parmar S, Oran B, Olson A, Rondon G, Chen J, Martinez C, Hamdi A, Mehta RS, Chemaly RF, Saunders IM, Bollard CM, Shpall EJ.

Biol Blood Marrow Transplant. 2015 Jul;21(7):1284-90. doi: 10.1016/j.bbmt.2015.02.017. Epub 2015 Feb 20.

42.

Non-inferiority of pulsed xenon UV light versus bleach for reducing environmental Clostridium difficile contamination on high-touch surfaces in Clostridium difficile infection isolation rooms.

Ghantoji SS, Stibich M, Stachowiak J, Cantu S, Adachi JA, Raad II, Chemaly RF.

J Med Microbiol. 2015 Feb;64(Pt 2):191-4. doi: 10.1099/jmm.0.000004-0. Erratum in: J Med Microbiol. 2015 May;64(Pt 5):586.

43.

Valganciclovir for the prevention of complications of late cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a randomized trial.

Boeckh M, Nichols WG, Chemaly RF, Papanicolaou GA, Wingard JR, Xie H, Syrjala KL, Flowers ME, Stevens-Ayers T, Jerome KR, Leisenring W.

Ann Intern Med. 2015 Jan 6;162(1):1-10. doi: 10.7326/M13-2729.

44.

Fecal colonization and infection with Pseudomonas aeruginosa in recipients of allogeneic hematopoietic stem cell transplantation.

Nesher L, Rolston KV, Shah DP, Tarrand JT, Mulanovich V, Ariza-Heredia EJ, Chemaly RF.

Transpl Infect Dis. 2015 Feb;17(1):33-8. doi: 10.1111/tid.12323. Epub 2014 Dec 27.

PMID:
25546740
45.

Topical cidofovir-induced acute kidney injury in two severely immunocompromised patients with refractory multidrug-resistant herpes simplex virus infections.

Saunders IM, Lahoti A, Chemaly RF, Trevino C, Westmoreland M, Hosing C.

J Oncol Pharm Pract. 2016 Apr;22(2):325-31. doi: 10.1177/1078155214560921. Epub 2014 Dec 7.

PMID:
25488905
46.

Infection control practices in patients with hematological malignancies and multidrug-resistant organisms: special considerations and challenges.

Ariza-Heredia EJ, Chemaly RF.

Clin Lymphoma Myeloma Leuk. 2014 Sep;14 Suppl:S104-10. doi: 10.1016/j.clml.2014.06.021. Review.

PMID:
25486947
47.

The role of the healthcare environment in the spread of multidrug-resistant organisms: update on current best practices for containment.

Chemaly RF, Simmons S, Dale C Jr, Ghantoji SS, Rodriguez M, Gubb J, Stachowiak J, Stibich M.

Ther Adv Infect Dis. 2014 Jun;2(3-4):79-90. doi: 10.1177/2049936114543287. Review.

48.

Vaccination guidelines after hematopoietic stem cell transplantation: practitioners' knowledge, attitudes, and gap between guidelines and clinical practice.

Ariza-Heredia EJ, Gulbis AM, Stolar KR, Kebriaei P, Shah DP, McConn KK, Champlin RE, Chemaly RF.

Transpl Infect Dis. 2014 Dec;16(6):878-86. doi: 10.1111/tid.12312. Epub 2014 Nov 18.

PMID:
25405922
49.

Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies.

Chemaly RF, Shah DP, Boeckh MJ.

Clin Infect Dis. 2014 Nov 15;59 Suppl 5:S344-51. doi: 10.1093/cid/ciu623. Review.

50.

Utility of routine surveillance blood cultures in asymptomatic allogeneic hematopoietic stem cell transplant recipients with indwelling central venous catheters at a comprehensive cancer center.

Nesher L, Chemaly RF, Shah DP, Mulanovich VE, Hosing C, Rolston KV.

Am J Infect Control. 2014 Oct;42(10):1084-8. doi: 10.1016/j.ajic.2014.07.004.

PMID:
25278398

Supplemental Content

Loading ...
Support Center